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The diagnosis of mucocutaneous leishmaniasis (MCL) is hampered by the absence of a gold standard. An accu-
rate diagnosis is essential because of the high toxicity of the medications for the disease. This study aimed to assess 
the ability of polymerase chain reaction (PCR) to identify MCL and to compare these results with clinical research 
recently published by the authors. A systematic literature review based on the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses: the PRISMA Statement was performed using comprehensive search criteria and 
communication with the authors. A meta-analysis considering the estimates of the univariate and bivariate models 
was performed. Specificity near 100% was common among the papers. The primary reason for accuracy differences 
was sensitivity. The meta-analysis, which was only possible for PCR samples of lesion fragments, revealed a sensitiv-
ity of 71% [95% confidence interval (CI) = 0.59; 0.81] and a specificity of 93% (95% CI = 0.83; 0.98) in the bivariate 
model. The search for measures that could increase the sensitivity of PCR should be encouraged. The quality of the 
collected material and the optimisation of the amplification of genetic material should be prioritised.
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American tegumentary leishmaniasis (ATL) is caused 
by parasites of the Leishmania genre. The clinical manifes-
tations of ATL are predominantly classified as cutaneous 
(CL) or mucocutaneous leishmaniasis (MCL), depending 
on the absence of mucous lesions or on the involvement of 
mucous membranes, respectively (Gomes et al. 2014b).
The etiologic diagnosis of ATL in all its forms is a dif-
ficult task. This difficulty is increased in cases of MCL, in 
which sampling frequently requires invasive techniques 
because of the potential presence of deep nasopharyngeal 
lesions (Maretti-Mira et al. 2011, Weinkopff et al. 2013).
The absence of a gold standard diagnostic test for 
MCL is a major obstacle. The existing tests cannot be in-
dependently used for the diagnosis of MCL because the 
accuracy of the tests is unsatisfactory. The classical di-
agnostic methods for MCL include immunological and 
parasitological tests. The immunological tests include the 
intradermal leishmanin test (the Montenegro skin test) 
and serological tests, which are known for their high sen-
sitivity; however, these immunological tests exhibit low 
diagnostic specificity (Ferreira et al. 2006, Gomes et al. 
2014a). The parasitological tests aim to directly identify 
the parasite and primarily consist of direct tests, culturing 
and histopathological examinations. Contrary to the ini-
tial tests, these latter tests have good specificity; however, 
they also exhibit poor sensitivity (Gomes et al. 2014a).
Studies have indicated that molecular biology tech-
niques, particularly polymerase chain reaction (PCR), 
offer good sensitivity and specificity and, ultimately, 
increased accuracy compared with immunological and 
parasitological tests (Medeiros et al. 2002, Garcia et 
al. 2005, Silva et al. 2012). However, several method-
ologies are used, making it difficult to generate simple 
comparisons among the papers.
We performed a systematic literature review of stud-
ies of the diagnostic accuracy of PCR in detecting MCL 
as part of our groups’ effort to develop non-invasive col-
lection methods for the diagnosis of MCL. The primary 
objective of this study was to assess the status of various 
molecular biology techniques in recognising MCL and 
to compare these data with the recent clinical research 
published by our group (Gomes et al. 2014a).
MATERIALS AND METHODS
This systematic literature review was performed based 
on recommendations by the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses: the PRISMA 
Statement, with adjustments for evaluating the diagnostic 
accuracy of the studies (Devillé et al. 2002, Leeflang et 
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al. 2008, Moher et al. 2009, Leeflang 2014). This review 
is registered with the platform PROSPERO - International 
Prospective Register of Systematic Review (University of 
York, UK), with the identifier CRD42014007038.
Paper selection - In January 2013, the following 
search terms were generated: “((((((mucosal) OR muco-
cutaneous) OR mucous)) AND leishmaniasis) AND di-
agnosis) AND Polymerase Chain Reaction”, using the 
advanced search system on the PubMed site (PubMed 
Advanced Search Builder) following the recommenda-
tions for searches with comprehensive criteria. Because 
MCL is a highly endemic disease in South America, pre-
dominantly in Brazil, we included the non-MeSH terms 
“mucous” and “mucosal”, which are frequently translat-
ed from the Portuguese words leishmaniose mucosa.
Two researchers were recruited to search the related 
references in the following databases or virtual libraries: 
PubMed, EMBASE, Web of Knowledge, SciELO and 
LILACS, using the same terms and connectors through 
each specific advanced search tool (Table I). No specific 
date was defined for applying the search criteria by each 
examiner. The paper search began in January 2013 and 
was concluded in December 2013. The inclusion and ex-
clusion criteria for the paper are detailed below.
Inclusion criteria - Papers that fulfilled all of the fol-
lowing criteria were selected and included. Addressed 
the topic: using PCR techniques for the diagnosis of 
MCL leishmaniasis, studies in humans, cases of mu-
cosal leishmaniasis potentially associated with skin le-
sions, more than seven cases of mucosal leishmaniasis, 
any number of controls without a diagnosis of mucosal 
leishmaniasis, no restriction for defining the controls 
(healthy, with mucosal or skin lesions) and written in 
English, French, Portuguese or Spanish.
Exclusion criteria - Fewer than eight cases of mucosal 
leishmaniasis, studies without controls, studies that used 
known cured cases of ATL as controls, studies in which 
patients with CL and mucosal leishmaniasis were in-
cluded without being explicitly separated, PCR tests con-
ducted with cultured patient samples, only the presence 
of exclusively CL forms of ATL and written in languages 
other than English, French, Portuguese or Spanish.
TABLE I
URLs for the search sources used in the systematic literature review that were accessed to conduct the survey of related articles
Database or virtual library Link 
PubMed ncbi.nlm.nih.gov/pubmed/
EMBASE aplicacao.periodicos.saude.gov.br/autenticar/profissional






A qualitative analysis tool created by the author based on clinical research previously conducted by this groupa 
Was there a sample size calculation?
Study site
Date of the study
Number of cases/positivity of the test performed
Inclusion criteria for the cases
 Number of controls/positivity of the test performed
Inclusion criteria for the controls
Sample studied
Method of DNA extraction
Primers used to amplify the genetic material, location of the target gene sequence and molecular weight of the amplified material
Method for visualising the amplified material
Sensitivity, specificity, positive predictive value, negative predictive value, accuracy and odds ratio of test evaluated
Species identified
a: (Gomes et al. 2014a).
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No restrictions were imposed on the paper selection 
process regarding the year of publication and no addi-
tional limits were set. Additionally, no restrictions were 
imposed regarding the reference composite standard for 
the diagnostic criteria of MCL. This characteristic was 
considered for the classification of selected papers and 
for the inclusion in the final meta-analysis model.
The papers were accessed using the periodicals 
portal available through the Brazilian Federal Agency 
for Support and Evaluation of Graduate Education on 
the internet-connected network of the University of 
Brasília and through direct contact with the authors via 
electronic correspondence.
After the search and review by the researchers, any 
disagreements were resolved by a third evaluator, who was 
blind to the identity of the researchers who conducted the 
previous selection. Electronic communications were sent to 
all of the corresponding authors of the selected papers with 
an inquiry regarding whether they knew of any published 
or unpublished study that addressed the criteria of interest. 
Additionally, the references cited in the pre-selected pa-
pers were examined for additional relevant studies. Thesis 
databases at several internationally recognised universities 
were searched as well (Supplementary data I).
The researchers constructed a 2 x 2 table based on 
the information contained in the papers with the aim of 
calculating the sensitivity, specificity, predictive values 
and accuracy using OpenEpi® v.3.01 (Emory University, 
Rollins School of Public Health, USA). After this proce-
dure, the corresponding authors of the selected papers 
were again contacted by email with the intent of retriev-
ing the data of papers in which it was impossible to con-
struct the 2 x 2 table and to confirm the precision of the 
accuracy data obtained after reading the papers.
Analysis of the selected papers - Two reviewers con-
ducted the qualitative analysis and paper critiques. The 
qualitative assessment was based on the completion of 
the tables, which were constructed during the above-
mentioned clinical study previously published by this 
group (Table II) (Gomes et al. 2014a). Any discrepancies 
in completing the qualitative table were resolved using 
an evaluation by a third examiner. 
The critical analysis was completed using the “QUA-
DAS tool: a tool for the quality assessment of studies 
TABLE III
Characteristics of the studies selected
Reference Location Design Cases included Sample
Size of the 
amplicons
(bp)
Piñero et al.  
(1999)
Cuzco/Peru Case-control Parasitological Blood 72
Pirmez et al.  
(1999)
Rio de Janeiro/Brazil Cross-sectional/cohort Clinical Biopsy 120
Victoir et al.  
(2003)
Lima/Peru Cross-sectional/cohort Polymerase chain 
reaction (PCR)
Biopsy 870
Disch et al.  
(2005)
Belo Horizonte/Brazil Case-control Clinical, immunological 
and parasitological
Biopsy 51,120
Camera et al.  
(2006)
Rio de Janeiro/Brazil Case-control Parasitological and PCR Blood 120
Bracho et al.  
(2007)
Bogotá/Colombia Case-control Clinical, immunological 
and parasitological
Biopsy 120, 1,000
Deborggraev et al.  
(2008)
Lima/Peru Case-control Parasitological Aspirate 115
Pereira et al.  
(2008)
Paraná/Brazil Cross-sectional/cohort Parasitological and PCR Biopsy 70, 750, 
103, 62
Fagundes et al.  
(2010)
Rio de Janeiro/Brazil Cross-sectional/cohort Parasitological Biopsy 120
Boggild et al.  
(2011)





Thomaz-Soccol et al. 
(2011)
Paraná/Brazil Cross-sectional/cohort Clinical, parasitological 
and PCR
Biopsy 70, 750
Veland et al.  
(2011)
Lima/Peru Case-control Parasitological and PCR Urine 70
Marco et al.  
(2012)
Salta/Argentina Cross-sectional/cohort Clinical, immunological 
and parasitological
Lesion scraping 168, 700, 
103, 79, 
79, 862
Neitzke-Abreu et al. 
(2013)
Maringá/Brazil Cross-sectional/ cohort Clinical, immunological 
and parasitological
Blood 70
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of diagnostic accuracy included in systematic reviews” 
(Whiting et al. 2006), which consists of 14 items rated 
as “yes”, “no” or “unclear”. Discrepancies between the 
data entered by the two evaluators were recorded under 
the ‘’unclear’’ classification.
The decision regarding which results would be in-
cluded in the meta-analysis was primarily resolved us-
ing criteria related to the test methodology. In this step, 
the study previously published by our group, which was 
the basis for performing this systematic review, was in-
cluded (Gomes et al. 2014a).
Analysis of the heterogeneity of the papers - In the 
first step, the papers were separated according to the 
composite reference standard used to define the cases 
and controls. The papers were classified according to 
the use of clinical, immunological, or/and parasitologi-
cal criteria (Table III).
In the second step, the following characteristics were 
considered: the sample analysed, molecular weight and the 
PCR primer target. Human tissue samples were considered 
similar whether they were stored in filter paper, paraffin-
ised or frozen (Marques et al. 2001). The DNA extraction 
methods that used commercial kits or phenol-extraction 
techniques were considered similar (Marques et al. 2001). 
Additionally, the studies that used primers that targeted 
the kDNA mini-circle of Leishmania spp and whose am-
plicons were less than 150 bp were considered similar. 
Statistical tests to evaluate the heterogeneity among the 
selected studies were not performed because of the limited 
number of papers with comparable methodologies.
Creating pooled forest plots - A sensitivity analysis 
considering the estimates of the univariate and bivariate 
models was performed (Deppen et al. 2014). The uni-
variate model was estimated with Meta-DiSc® software 
(Ramón y Cajal University Hospital, Spain) and the bi-
variate model was fitted in R® software, v.3.1.2, using 
the mada package (Institute for Statistics and Mathemat-
ics of Wirtschaftsuniversität, Austria). This library esti-
mates the parameters by the restricted maximum likeli-
hood method. All of the tests were bimodal (2-sided) and 
applied a 5% type I error rate.
RESULTS
At the end of the selection process, 14 papers were 
included based on the above-mentioned criteria (Fig. 1, 
Supplementary data II): Piñero et al. (1999), Pirmez et al. 
(1999), Victoir et al. (2003), Disch et al. (2005), Camera et 
al. (2006), Bracho et al. (2007), Deborggraeve et al. (2008), 
Pereira et al. (2008), Fagundes et al. (2010), Boggild et al. 
(2011), Thomaz-Soccol et al. (2011), Veland et al. (2011), 
Marco et al. (2012) and Neitzke-Abreu et al. (2013).
Qualitative meta-synthesis of the results - Regard-
ing location, seven studies were conducted in Brazil, all 
of which were in the south and southeastern regions of 
the country, in which Leishmania (Viannia) brazilien-
sis species are endemic. Five studies were conducted in 
Peru, one in Colombia and one in Argentina. Five of the 
14 papers included only patients with MCL. The remain-
ing studies combined cases of MCL and CL.
One of the main reasons for heterogeneity among the 
selected papers was the composite reference standard 
Fig. 1: a flowchart of paper selection and inclusion.
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used to define cases of MCL and controls. The patients 
were selected based on the compilation of clinical, epi-
demiological and parasitological criteria in only three 
studies. A common error observed in six papers was the 
inclusion of a PCR test to determine the inclusion and 
allocation criteria. Of the remaining studies, three used 
parasitological criteria, one used clinical criteria and one 
did not report the diagnostic criteria used.
One paper clearly stated the calculation of a sample 
size (Boggild et al. 2011) considering only the expected 
sensitivity of the tested diagnostic methods. Seven pa-
pers used a case-control design, whereas the other one-
half of the papers used a cross-sectional/cohort design 
for the recruitment and allocation (Table III).
With respect to the type of samples analysed, three 
used blood samples, one used urine samples, one used 
TABLE IV
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a: true positives; b: false positives; c: amplicon size; d: polymerase chain reaction target; e: collected material; f: primers; CI: 
confidence interval; NPV: negative predictive value; PPV: positive predictive value. Publications with more than one collection 
or amplification method were subdivided.
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lesion scrapings, one used lesion aspirates, one used na-
sal swabs and biopsies and seven used tissue samples 
collected by biopsy. The data on the positivity and char-
acteristics of the tests are detailed in Tables II, IV. The 
studies that exhibited greater accuracy for MCL using 
PCR were performed using tissue samples (Deborg-
graeve et al. 2008, Boggild et al. 2011).
With respect to the properties of the diagnostic tests, 
specificity tended to be the highest. Ten papers had a spe-
cificity of 100% and two reported a specificity of less than 
90%. The level of sensitivity reported in most of the papers 
was between 60-90%. Two papers reported sensitivities 
below 50% and one paper reported a sensitivity of 100%.
Critical analysis of the selected papers - The analysis 
was performed using the QUADAS tool (Fig. 2) and indi-
cated that the largest amount of data not reported in the pa-
pers (a “no” response) were related to the last two questions, 
which inquired about inconclusive results and records for 
the loss of patients in the studies. The cases in which the 
response was ‘’unclear’’ were most frequently observed for 
questions 10, 11 and 12, thus indicating that the selected 
papers did not obviously report whether the examiner was 
blind to the reference standard during the application of 
the evaluated test and vice versa. This result additionally 
indicated that most of the papers did not explicitly detail 
whether the data evaluated in the present study were con-
sistent with the data used in clinical practice.
Papers published during or after 2010 were of higher 
quality according to the QUADAS tool than the papers 
published prior to this date (Fig. 2).
Creating pooled forest plots - After the methodologi-
cal evaluation, only three papers were considered suf-
ficiently similar and were selected: Disch et al. (2005), 
Bracho et al. (2007) and Thomaz-Soccol et al. (2011). 
It was possible to compare the results in these studies 
to clinical research previously performed by this group; 
however, this comparison was restricted to tissue sam-
ples (Gomes et al. 2014a).
The joint estimates of sensitivity and specificity in 
the univariate and bivariate models are presented in Ta-
ble V and Fig. 3. The area under the receiving operating 
characteristics (ROC) curve, considering the bivariate 
model, was estimated at 0.94 (Fig. 4).
DISCUSSION
Some authors have reported that systematic reviews 
on diagnostic accuracy testing tend to result in studies 
of differing quality compared with reviews that examine 
clinical trials (Devillé et al. 2002, Leeflang et al. 2008, 
Leeflang 2014). Additionally, papers regarding diagnostic 
accuracy have considerable methodological heterogeneity 
compared with that of intervention studies. For this rea-
son, it is not always possible to complete a meta-analysis 
(Devillé et al. 2002). The full methodological procedures 
are frequently not described within the papers and to un-
derstand these procedures, one must conduct a detailed 
reading of one or more papers cited by the authors.
Definition of cases and controls (the use of a composite 
reference standard) - The definition of cases and controls 
exerts a fundamental influence on the results of accuracy 
TABLE V
Joint estimates of sensitivity and specificity  















Fig. 2: “QUADAS: a tool for the quality assessment of studies of di-
agnostic accuracy included in systematic reviews”. The answers of 
the two examiners to the 14 items included in the tool. Disagreements 
between the two examiners were classified as “unclear’’.
Fig. 3: a forest plot of the pooled data for sensitivity and specificity - R® 
software v.3.1.2 using the mada package (Institute for Statistics and Math-
ematics of Wirtschaftsuniversität, Austria). CI: confidence interval. 
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diagnostic studies. Variations in these criteria were one 
of the most frequent points of heterogeneity among the 
papers (Table III). Recent systematic reviews of the litera-
ture focused on the diagnosis of kala-azar have reported 
the same problems regarding the classification of cases 
and controls, which appears to be a major concern for all 
of the clinical manifestations of leishmaniasis, including 
MCL (Adams et al. 2013, de Ruiter et al. 2014).
Defining cases using only parasitological tests sub-
stantially increased the sensitivity of PCR because para-
sites were abundant in these cases. However, these case 
definitions did not correspond to clinical practice. Infec-
tion by L. (V.) braziliensis is known for its low density 
of parasites and severe local inflammation (Brelaz-de-
Castro et al. 2012). This species is the primary cause of 
MCL and a considerable percentage of these patients do 
not exhibit positivity using parasitological techniques.
Additionally, defining controls is crucial. The pos-
sible inclusion of patients with previously cured MCL or 
those undergoing treatment might reduce the specificity 
of the tests. These patients might continue to harbour 
Leishmania cell debris or even the latent form of the 
parasite without manifesting the clinical disease (Men-
donça et al. 2004). We evaluated the procedures used to 
define cases of MCL and controls (Tables II, III) to de-
fine which papers were comparable for inclusion in the 
meta-analysis model.
Properties of the diagnostic tests - The results re-
vealed that the major factor responsible for the variations 
in diagnostic accuracy among the studies was the sensi-
tivity value. It is difficult to assign a specific reason for 
increases or decreases in sensitivity. However, an unbi-
ased analysis of the results supports the conclusion that 
specificity remains relatively stable even with extreme 
increases in sensitivity. Factors such as reductions in the 
molecular weight of the fragments amplified by primers 
and the use of commercial kits to extract DNA did not 
increase the proportion of false positive tests. This infor-
mation was confirmed using an analysis of the generated 
the summary ROC curve (Fig. 4).
Random effects bivariate logit-normal sensitivity 
and specificity estimates are recommended for meta-
analyses of diagnostic studies (Simel & Bossuyt 2009). 
However, these estimates are considered more complex 
methodologies (Simel & Bossuyt 2009). Some authors 
suggest that the use of univariate methods is not likely to 
result in significant changes. An analysis of the pooled 
results in the univariate and bivariate models confirmed 
similarities between the methods (Table V).
These results confirmed the high specificity of the 
PCR techniques for the diagnosis of MCL, which could 
be considered an important advantage compared with the 
unspecific immunological tests. In addition, the sensitiv-
ity was greater than the values described for the parasito-
logical tests (Gomes et al. 2014b). These results confirm 
previous reports that consider PCR to be the most accurate 
method for the diagnosis of MCL (Gomes et al. 2014a).
Limitations - One of the most important limitations 
of this study is that we excluded studies with fewer than 
eight cases of MCL. This decision aimed to define a 
minimal relevance of studies because of an initial inten-
tion to include non-controlled studies and to use only 
simpler univariate methods of aggregation. This proce-
dure was based on existing recommendations for sample 
size calculation in diagnostic test studies. As an exam-
ple, a sample size of eight patients would only be suffi-
cient if a low confidence interval inferior limit were set 
in association with an expected sensitivity level greater 
than 95%, which is not realistic for the diagnosis of MCL 
(Flahault et al. 2005, Bailly et al. 2014). We hypothesise 
that the existence of a considerable quantity of references 
with fewer than eight cases that fulfil all of the inclusion 
criteria is not probable. In addition, studies with a sam-
ple size that is insufficiently small would have a lower 
influence on the final result of the meta-analysis.
The use of QUADAS was selected instead of its more 
recent version QUADAS 2. Although the methods meas-
ure identical characteristics, the newer version allows 
a written description of four key domains (patient se-
lection, index test, reference standard and flow/timing) 
(Whiting et al. 2011). Because we constructed a simpli-
fied tool that covered these domains and the domains 
related to molecular biology procedures (Table II), we 
decided to use the QUADAS for simplicity and to avoid 
the duplication of data collection. The absence of a third 
reviewer for the analysis of the QUADAS classification 
(Fig. 2) could have reduced the precision of this proce-
dure. We reasonably considered that any mistake occur-
ring during the classification would be highly influenced 
by an unclear description of the methodologies. In this 
case, the discrepancies were classified as “unclear”.
The heterogeneous application of the composite ref-
erence standard in the selected papers ensures that it is 
difficult to separate the patients with CL or MCL. The 
simultaneous inclusion of these two forms of ATL was 
identified in nine studies, which may have increased the 
risk of bias during the extraction of the data from the stud-
Fig. 4: summary receiving operating characteristics curve (SROC): 
the relationship between sensitivity and specificity - R® software 
v.3.1.2 (Institute for Statistics and Mathematics of Wirtschaftsuniver-
sität, Austria).
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ies. After constructing the 2 x 2 table and calculating the 
sensitivity, specificity, predictive values and accuracy, the 
authors of previously selected papers were contacted by 
email to retrieve the incomplete data and confirm the ac-
curacy of the data. This approach aimed to reduce possible 
discrepancies between the accomplishments of the study 
and the possible interpretations of the scientific paper.
Recommendations - This systematic literature re-
view analyses the available data on the PCR techniques 
used in the diagnosis of MCL. The significant meth-
odological heterogeneity makes comparisons between 
studies more difficult.
Based on these results, it is necessary to generate 
a consensus and protocols that recommend optimised 
practices for PCR in MCL (da Graça et al. 2012). It is pos-
sible to infer that the use of techniques aimed to increase 
the sensitivity of the tests should be pursued, particularly 
because the specificity is generally satisfactory. The tis-
sue samples collected directly from the lesion and the use 
of high-sensitivity extraction methods must be observed 
in the preparation for PCR processing. Additionally, the 
targeted DNA sequence must be observed because the 
primers that amplify the kDNA sequences of Leishma-
nia exhibited better sensitivity than other sequences (van 
den Bogaart et al. 2013). Additionally, related techniques, 
such as real-time quantitative PCR, might be used to im-
prove sensitivity (van den Bogaart et al. 2013).
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